INTECH Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

INTECH Investment Management’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-48,563	Closed	-$148K	–	2576
2024 Q4	$148K	Buy	48,563 +4,068	+9%	+$17.7K	﹤0.01%	2118
2024 Q3	$231K	Buy	+44,495	New	+$221K	﹤0.01%	1656

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

INTECH Investment Management's RVNC Position: Q1 2025 in Review

INTECH Investment Management sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 48,563 shares — an estimated $148K sold.

INTECH Investment Management first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $231K in Q3 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

INTECH Investment Management reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
INTECH Investment Management sold 48,563 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $148K.
INTECH Investment Management first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
INTECH Investment Management's Revance Therapeutics, Inc. position peaked at $231K in Q3 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on INTECH Investment Management's 13F filing for Q1 2025, filed 20 May 2025.